Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Jun JiangCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID 0000-0002-3526-3797
David Baliu-RodriguezBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID 0000-0001-5630-8475
A Daniel McCarttCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID 0000-0002-7079-8447
Ted OgnibeneCenter for Accelerator Mass Spectrometry, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.
Michael A MalfattiBiosciences and Biotechnology Division, Lawrence Livermore National Laboratory, Livermore, California 94550, United States.ORCID 0000-0003-2431-9115
Donglu ZhangDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., MS412a, South San Francisco, California 94080, United States.
Shuguang MaDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., MS412a, South San Francisco, California 94080, United States.
S Cyrus KhojastehDepartment of Drug Metabolism and Pharmacokinetics, Genentech, Inc., MS412a, South San Francisco, California 94080, United States.
Funding
National User Resource for Biological Accelerator Mass SpectrometryR24GM137748 · NIGMS · LAWRENCE LIVERMORE NATIONAL SECURITY, LLC · PI BENCH, GRAHAM · 2020 to 2024
$6.5M
Development of an ultra-sensitive, laser-based, carbon-14 spectrometer for molecular speciation of liquid-chromatography analytes and small, biological samplesR01GM127573 · NIGMS · UNIVERSITY OF CALIF-LAWRNC LVRMR NAT LAB · PI MCCARTT, ALAN DANIEL · 2018 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.